New Delhi: Through a recent order the apex drug price controller, National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 29 drug formulations. Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more
In the recent order issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof:
Each film-coated extended-release tablet contains:
Metoprolol Succinate IP 95mg eq.
M/s Swiss Garnier Genexia
Sciences Pvt. Ltd. / M/s
M/s Swiss Garnier Genexia
Sciences Pvt. Ltd. / M/s
M/s Swiss Garnier Genexia
Sciences Pvt. Ltd. / M/s
Trypsin & Chymotripsin + Paracetamol + Aceclofenac Tablet (Zerodol TC
Each film-coated tablet contains: 50,000 Armour Units Enzymatic Activity Supplied by purified concentrate which has specific Trypsin & Chymotripsin activity in a ratio of approximately six to One (as enteric-coated granuales) Paracetamol IP 325mg, Aceclofenac IP 100mg
Emtricitabine + Tenofovir Alafenamide Tablet (TAFNAT-EM)
Each film coated Tablet contains:
eq. to Tenofovir Alafenamide 25mg
M/s Natco Pharma Limited
Each ml syrup contains: Chlorpheniramine Maleate IP 2mg, Phenylephrine Hydrocloride IP 5mg
M/s Windlas Biotech Pvt.
Ltd. / M/s Zydus Healthcare
M/s Windlas Biotech Pvt.
Ltd. / M/s Zydus Healthcare
M/s Windlas Biotech Pvt.
Ltd. / M/s Zydus Healthcare
Each hard gelatine capsule contains:
Atorvastatin Calcium IP eq. to
Clopidogrel Bisulphate IP eq. to
Aspirin IP 75mg (As enteric coated
M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd
20mg,Clopidogrel Bisulphate IP eq.
to Clopidogrel 75mg,Aspirin IP
75mg (As enteric coated pellets)
M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.
Each film-coated Bilayered Tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg, Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (As Extended-Release)
M/s Micro Labs Limited
eq. to Metoprolol Tartrate 50mg (As
M/s Micro Labs Limited
Each Film-coated tablet contains: Tranexamic Acid IP 250mg
M/s Pharma Synth Formulations Ltd/ M/s La Prisine Bioceuticals Pvt. Ltd
Each hard gelatin capsule contains:
IP eq. to Esomeprazole 40mg (as
Domperidone IP 30mg (as sustained
M/s East African (India)
Hydrate eq. to Teneligliptin 20mg
M/s Pure & Cure Healthcare
Folic Acid + Methylcobalamin Tablet (FDSON-12 SL)
M/s Unison Pharmaceuticals Pvt. Ltd.
Calcium Carbonate IP 1.250g, eq. to
Each hard gelatin capsule contains: Esomeprazole Magnesium Trihdrate IP eq. to Esomeprazole 40mg (as enteric coated pellets) Domperidone IP 30mg (as sustained release pellets)
M/s Nest Healthcare Pvt.
Temisartan IP 40mg, Metoprolol Succinate IP 23.75mg
eq. to Metoprolol Tartrate IP 25mg
Each film-coated bilayered Tablet contains: Temisartan IP 40mg, Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate IP 50mg (As extended Release)
M/s Sun Pharma Laboratories Limited
M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd
Each film coated tablet contains:
Domperidone Maleate IP eq. to
Naproxen Sodium USP 275mg eq.
Each film coated tablet contains:
Domperidone Maleate IP eq. to
Naproxen Sodium USP 550mg eq.
M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Pvt. Ltd.
Each uncoated tablet contains: Gliclazide IP 80mg, Metformin Hydrochloride IP 500mg
M/s Innova Captab Limited / M/s Abbott Healthcare Pvt. Ltd
Thiocolchicoside + Aceclofenac + Paracetamol Tablet (Zerodol TH 4 Max)
Each Film Coated Tablet contains: Thiocolchicoside IP 4mg, Aceclofenac IP 100mg, Paracetamol IP 325mg
Each Film Coated Tablet contains:
Water for Injection (GALLINI I.V.)
Each 100ml contains: Linezolid IP 200mg Dextrose Anhydrous IP 5g Water for Injection
(a) The manufacturer of the above-mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
To read the full article click on the following link:
https://business.medicaldialogues.in/pdf_upload/pdf_upload-126340.pdf
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
• Email: info@medicaldialogues.in • Phone: 011 - 4372 0751
This site complies with the HONcode standard for trustworthy health information: verify here.
Search only trustworthy HONcode health websites: